Acetylcholine-induced NO- and EDHF-mediated relaxations decrease with increasing age. by Noureddine Idris Khodja (331400)

OSU-HDAC-44 decreased RhoA activity via srGAP1 induction, leading to F-actin dysregulation. by Yen-An Tang (187547)

“…<p>(<b>A</b>) Chromatin-immunoprecipitation-PCR analyses confirmed that treatment with 2.5 µM OSU-HDAC-44 for 2 h induced acetylation of histone H3 (H3K9K14Ac) in the promoter region of <i>srGAP1</i>, <i>NR4A1</i> and <i>FOXO4</i> genes. …”

DDX5 and DDX17 interact with KSHV vPK and EBV BGLF4. by Praneet Kaur Sandhu (21156149)

Early increase and later decrease in GSK-3β activity. by Arie J. Hoogendijk (353624)

DataSheet1_Physiologically Based Pharmacokinetic Modeling in Pregnant Women Suggests Minor Decrease in Maternal Exposure to Olanzapine.docx by Liang Zheng (206933)

Decrease in arginine and increase in citrulline after NEI-01 administration. by Jeremy P. H. Chow (8788208)

Slow exponential decrease of tonic pupil size over time. by Tomas Knapen (33341)

NBCe1 and NBCe2 protein and mRNA expression in hRPTCs carrying wild-type (WT) or homozygous variant (HV) <i>SLC4A5</i>. by John J. Gildea (845025)

“…<b>D) <i>SLC4A4</i> mRNA.</b> <i>SLC4A4</i> mRNA is decreased following an increase in intracellular sodium (monensin, 1 μmol/L, 24 h) (↑Na⁺) only in WT <i>SLC4A5</i> hRPTCs (N = 9, *P<0.05 vs. …”

Nilotinib inhibition of HEI-193 decreases signaling downstream of PDGFR. by Nesrin Sabha (127278)

24 hours of ARD results in noticeable decrease in ORO staining. by Moriah Eustice (13813098)

“…<p>(A) Decrease in ORO signal were observable at 24 hr after worms were placed on ARD plates (as compared to control fed worms in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0274076#pone.0274076.g005" target="_blank">Fig 5</a>), as shown with representative strains. …”

miR-210 and hypoxia decrease ROD1 expression. by Pasquale Fasanaro (134953)

Reduced ADAMTS-12 expression levels decrease EVT invasion. by Alexander G. Beristain (225001)

rhSP-D decreases viability of AML14.3D10 cells in a dose and time dependent manner. by Lakshna Mahajan (504239)

Decrease of actin velocity when passing confined TCR clusters. by Cheng-han Yu (244912)

Image_2_JK5G postbiotics attenuate immune-related adverse events in NSCLC patients by regulating gut microbiota: a randomized controlled trial in China.tif by Mengting Chen (1419172)

“…Moreover, the JK5G group had a lower incidence of anemia (63.33% vs. 13.33%, p < 0.001), decreased lymphocyte count (20.00% vs. 0%, p = 0.010), decreased appetite (53.33% vs. 16.67%, p = 0.003), nausea (33.33% vs. 6.67%, p = 0.010), and asthenia (30.00% vs. 6.67%, p = 0.017) than the control group. …”

Exposure to biologics during pregnancy does not affect placental antibody transfer of anti-SARS-CoV-2 neutralizing antibodies, but concomitant corticosteroid exposure may decrease... by Donna E. Leet (22772478)

Image 1_Effects of traditional Chinese exercises on post-stroke depression: a meta-analysis of randomized controlled trials.pdf by Yan Li (23143)

“…<p>Post-stroke depression (PSD) is a common complication that worsens neurological recovery and increases mortality among stroke survivors, creating a significant burden on patients and families. …”

Table 1_Effects of traditional Chinese exercises on post-stroke depression: a meta-analysis of randomized controlled trials.docx by Yan Li (23143)

“…<p>Post-stroke depression (PSD) is a common complication that worsens neurological recovery and increases mortality among stroke survivors, creating a significant burden on patients and families. …”

Words for describing activities that decrease and/or increase Subjective Well-Being. by August Håkan Nilsson (12937056)

“…<p><i>Note</i>: Supervised dimension projection plot for activities that increase and/or decrease SWB. Words appearing a minimum of 5 times in the questions combined have been significance tested against a permuted null distribution, <i>N</i>_{<i>permutations</i>} = 200,000. …”

Data Sheet 5_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)